| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $51.6M | +54.4% |
| Cost of Revenue | $43.9M | +56.4% |
| Gross Profit | $7.7M | +43.5% |
| R&D Expense | $1.5M | — |
| SG&A Expense | $28.0M | +188.7% |
| Operating Income | -$22.1M | -275.3% |
| Interest Expense | $3.3M | -39.8% |
| Pre-tax Income | -$21.4M | -163.1% |
| Income Tax | -$1.9M | -1988.9% |
| Net Income | -$19.5M | -142.0% |
| EPS (Basic) | -$0.12 | -100.0% |
| EPS (Diluted) | -$0.12 | -100.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | +1237.8% |
| Accounts Receivable | $11.9M | +83.1% |
| Inventory | $24.4M | +815.8% |
| Current Assets | $42.8M | +303.3% |
| Total Assets | $134.6M | +230.5% |
| Current Liabilities | $30.4M | +80.7% |
| Total Liabilities | $63.1M | +27.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.4M | -1124.7% |
| Capital Expenditures | $3.6M | +4619.5% |
| Investing Cash Flow | -$41.2M | -1827.9% |
| Financing Cash Flow | $69.6M | +1402.5% |
| Free Cash Flow | -$29.0M | -1247.6% |
| Stockholders' Equity |
| $71.5M |
| +913.5% |